Therapeutic Targets In Lung Cancer - Cancer Science

Relevant Publications

Differential expression profiles and functional prediction of circular RNAs in lung cancer patients with chronic obstructive pulmonary disease: a pilot study.

Issue Release: 2024

Discovery of a first-in-class protein degrader for the c-ros oncogene 1 (ROS1).

Issue Release: 2024

Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer.

Issue Release: 2024

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.

Issue Release: 2024

Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma.

Issue Release: 2024

LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer.

Issue Release: 2024

SENP2-NDR2-p21 Axis Modulates Lung Cancer Cell Growth.

Issue Release: 2024

Circular RNAs in tuberculosis and lung cancer.

Issue Release: 2024

A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.

Issue Release: 2024

Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer.

Issue Release: 2024

Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer.

Issue Release: 2024

The rapidly changing field of predictive biomarkers of non-small cell lung cancer.

Issue Release: 2024

Icariside II in NSCLC and COVID-19: Network pharmacology and molecular docking study.

Issue Release: 2024

Enhancing the revelation of key genes and interaction networks in non-small cell lung cancer with major depressive disorder: A bioinformatics analysis.

Issue Release: 2024

FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression.

Issue Release: 2024

MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability.

Issue Release: 2024

Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients.

Issue Release: 2024

Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).

Issue Release: 2024

Small-cell lung cancer neuronal features and their implications for tumor progression, metastasis, and therapy.

Issue Release: 2024

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Partnered Content Networks

Relevant Topics